BR9816047A - Método de utilização de neuroimunofilinas para radioproteção neuronal seletiva; método aperfeiçoado; uso de ligantes de neuroimunofilinas e artigo fabricado - Google Patents

Método de utilização de neuroimunofilinas para radioproteção neuronal seletiva; método aperfeiçoado; uso de ligantes de neuroimunofilinas e artigo fabricado

Info

Publication number
BR9816047A
BR9816047A BR9816047-8A BR9816047A BR9816047A BR 9816047 A BR9816047 A BR 9816047A BR 9816047 A BR9816047 A BR 9816047A BR 9816047 A BR9816047 A BR 9816047A
Authority
BR
Brazil
Prior art keywords
manufactured article
neuroimmunophilins
neuroimmunophilin
radioprotection
binders
Prior art date
Application number
BR9816047-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Marcus Keep
Elmer Eskil
Original Assignee
Marcus Keep
Elmer Eskil
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marcus Keep, Elmer Eskil filed Critical Marcus Keep
Publication of BR9816047A publication Critical patent/BR9816047A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BR9816047-8A 1998-09-23 1998-09-23 Método de utilização de neuroimunofilinas para radioproteção neuronal seletiva; método aperfeiçoado; uso de ligantes de neuroimunofilinas e artigo fabricado BR9816047A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/020040 WO2000016794A1 (fr) 1998-09-23 1998-09-23 Neuro-immunophillines pour radioprotection neuronale selective

Publications (1)

Publication Number Publication Date
BR9816047A true BR9816047A (pt) 2003-01-07

Family

ID=22267931

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9816047-8A BR9816047A (pt) 1998-09-23 1998-09-23 Método de utilização de neuroimunofilinas para radioproteção neuronal seletiva; método aperfeiçoado; uso de ligantes de neuroimunofilinas e artigo fabricado

Country Status (10)

Country Link
EP (1) EP1115412A4 (fr)
JP (1) JP2002526453A (fr)
CN (1) CN1322136A (fr)
AP (1) AP2001002113A0 (fr)
AU (1) AU766095B2 (fr)
BR (1) BR9816047A (fr)
CA (1) CA2345378A1 (fr)
HK (1) HK1040617A1 (fr)
IL (1) IL142120A0 (fr)
WO (1) WO2000016794A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE314084T1 (de) 2000-10-31 2006-01-15 Pharma Mar Sa Kahalalid f formulierung
WO2005103255A1 (fr) * 2004-03-25 2005-11-03 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Recepteur formylpeptide (fpr) utilise en tant que cible pour une therapie anti-gliome malin
US11745029B2 (en) 2018-05-30 2023-09-05 Zap Surgical Systems, Inc. Radiosurgical neuromodulation close to critical structures

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE520730C2 (sv) * 1995-01-20 2003-08-19 Eskil Elmer Behandling av hjärnischemi och hjärnskador med ett neuroprotektivt läkemedel
JP3089350B2 (ja) * 1995-11-20 2000-09-18 ギルフォード ファーマシューティカルズ インコーポレイテッド シクロフィリンロタマーゼ活性の阻害剤

Also Published As

Publication number Publication date
CN1322136A (zh) 2001-11-14
CA2345378A1 (fr) 2000-03-30
AU9508198A (en) 2000-04-10
IL142120A0 (en) 2002-03-10
AP2001002113A0 (en) 2001-06-30
AU766095B2 (en) 2003-10-09
HK1040617A1 (zh) 2002-06-21
JP2002526453A (ja) 2002-08-20
EP1115412A4 (fr) 2004-12-15
WO2000016794A1 (fr) 2000-03-30
EP1115412A1 (fr) 2001-07-18

Similar Documents

Publication Publication Date Title
BR0015110A (pt) Métodos de tratamento de doenças de proliferação celular, de tratamento de um distúrbio associado com a atividade da cinesina ksp, de inibição da cinesina ksp, de triagem de moduladores da cinesina kps e de triagem de compostos que se ligam na cinesina ksp, e, compostos
BR9603472A (pt) Conjunto de protetor e processo de proteção adequado para uso em dispositivo de comunição
BR9104565A (pt) Pseudoceramida sintetica,processo para sintetizar a mesma,composicao e processo para tratar a pele
IS4769A (is) Píperasín afleiður sem hafa verkjastillandi áhrif, framleiðsla og notkun þeirra
AU1221600A (en) Cardiac rhythm management device with detection and therapy for sudden syncopal events
ES2126887T3 (es) Composiciones bronceadoras artificiales con estabilidad mejorada.
ATE221881T1 (de) Tetralin-verbindungen mit multi-drugresistenz (mdr)-aktivitat
DE69521509T2 (de) Vorrichtung zum schutz gegen überspannung von bolzen, schrauben und dergleichen
SE9802208D0 (sv) Novel compounds
EE03851B1 (et) Amiinide kasutamine kasvajarakkude paljunemise takistamiseks mõeldud ravimite tootmiseks
DE69920949D1 (de) Ascomycin enthaltende topische zubereitungen
IL59378A (en) 1-allyltriazole derivatives,their preparation and their use as plant protecting agents
BR9816047A (pt) Método de utilização de neuroimunofilinas para radioproteção neuronal seletiva; método aperfeiçoado; uso de ligantes de neuroimunofilinas e artigo fabricado
EE200100079A (et) Taksoidi derivaatide kasutamine ravimi valmistamiseks, mis on ette nähtud rakkude ebaloomuliku proliferatsiooni raviks imetajate ajus
MX210235B (es) Oxiranil-triazolintionas y su empleo como microbicidas
HUP0200969A3 (en) Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders os mixed anxiety-depression disorders
BR9100519A (pt) Composto,composicao farmaceutica,metodo para inibicao de colinesterase em um mamifero e metodo para melhorar a memoria ou tratar ou prevenir a doenca de alzheimer
AT378462B (de) Vorrichtung zur gleichmaessigen dosierung, verteilung und aufbringung von fluessig formulierten schutzstoffen, insbesondere beizmitteln
EE9400296A (et) Piperidinüültioindooli derivaadid, ravimvormid, aktiivne valuvaigisti, nende valmistamise meetodid
BR0208860A (pt) Uso de um derivado de dextrano catiÈnico, método para a proteção de um indivìduo contra o dano em órgãos com limitação de dose, e, método para a proteção de um indivìduo contra dano renal
NO942230D0 (no) Substituerte benzimidazoler, fremgangsmåte for deres fremstilling samt deres anvendelse
WO1999045103A3 (fr) Lignees cellulaires de moelle epiniere humaine et techniques d'utilisation correspondantes
NO308528B1 (no) Substituerte 1-naftoylguanidiner, deres anvendelse for fremstilling av medikamenter samt helbredende middel inneholdende forbindelsene
EP0814845A4 (fr) Traitement de tumeurs par transduction avec des marqueurs selectifs negatifs, application d'agents d'interaction et exposition subsequente a des radiations
Long Georges Depeyrot, Le Bas-Empire romain: Économie et numismatique (284-491), Collection des Hesperides (Paris: ditions Errance 1987)

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE COMO INVENCAO, DE ACORDO COM ARTIGO 8O DA LPI